title: [Effectiveness of treatment of pancreatic disorders in children (based on catamnesis)].
abstract: In the article results of supervision of the patients with chronic pancreatitis and dysfunction of Oddi's sphincter, pancreatic type, in polyclinic were presented. Among them: 50 children received in clinic therapeutic complex offered by us which included: phytoenzyme, spasmolytic and antioxidant. 50 children were treated in traditional way. Screening of functional condition of the pancreas revealed decreasing percentage of moderate exocrine insufficiency of pancreas (10% of incidences) in children with recurrent course of pancreatitis. In long-lasting course of pancreatitis in this group percentage of patients with moderate exocrine insufficiency was decreased due to 15%. At the same time, in patients with moderate and severe exocrine insufficiency (55 and 20% subsequently) which improves non complete efficiency of basic therapy.
authors.forename: I S
authors.initials: IS
authors.lastname: Lembrik
mesh_terms: D000293:Adolescent; D002096:C-Peptide / Q000378:metabolism; D002648:Child; D005243:Feces / Q000737:chemistry; D005260:Female; D005500:Follow-Up Studies; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D010196:Pancreatic Elastase / Q000378:metabolism; D050500:Pancreatitis, Chronic / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D010447:Peptide Hydrolases / Q000627:therapeutic use*; D011794:Quercetin / Q000627:therapeutic use*; D012720:Severity of Illness Index; D009803:Sphincter of Oddi / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D016896:Treatment Outcome; D014287:Trimebutine / Q000627:therapeutic use*
chemical_list: D002096:C-Peptide; D005765:Gastrointestinal Agents; D011794:Quercetin; D010447:Peptide Hydrolases; D010196:Pancreatic Elastase; D014287:Trimebutine